Form 8-K - Current report:
SEC Accession No. 0001193125-25-249438
Filing Date
2025-10-24
Accepted
2025-10-24 09:19:59
Documents
18
Period of Report
2025-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70157d8k.htm   iXBRL 8-K 71792
2 EX-2.1 d70157dex21.htm EX-2.1 680435
3 EX-10.1 d70157dex101.htm EX-10.1 112932
4 EX-99.1 d70157dex991.htm EX-99.1 25780
8 GRAPHIC g70157dsp1a.jpg GRAPHIC 5739
9 GRAPHIC g70157dsp1aa.jpg GRAPHIC 7912
10 GRAPHIC g70157dsp1b.jpg GRAPHIC 6976
  Complete submission text file 0001193125-25-249438.txt   1260249

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA advm-20251024.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20251024_lab.xml EX-101.LAB 17234
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20251024_pre.xml EX-101.PRE 10811
21 EXTRACTED XBRL INSTANCE DOCUMENT d70157d8k_htm.xml XML 3516
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 251414495
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)